NCT06840886 2026-04-22A Study of PHST001 in Advanced Solid TumorsPheast TherapeuticsPhase 1 Recruiting272 enrolled
NCT02465060 2026-04-13Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)National Cancer Institute (NCI)Phase 2 Active not recruiting6,452 enrolled 2 FDA
NCT05919264 2026-04-09FOG-001 in Locally Advanced or Metastatic Solid TumorsParabilis Medicines, Inc.Phase 1/2 Recruiting595 enrolled
NCT05142033 2026-03-27ASAPAvera McKennan Hospital & University Health CenterRecruiting25,000 enrolled
NCT04851119 2026-02-24Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid TumorsChildren's Oncology GroupPhase 1/2 Recruiting147 enrolled